Immunic Therapeutics

IR Contact

Ukrainian Flag

Immunic is committed to support all our patients participating in clinical trials. We are currently reviewing the fluid situation in Ukraine, but want to support you to have access to your study medication.

If you require support, please send us your Patient Number in your clinical study and the site (location) where you were originally enrolled. If possible, please do not provide us with your full name or other personal information.

If you are an ongoing study participant from Ukraine and have relocated, please contact the following mobile numbers via WhatsApp, Viber or Telegram for further information regarding potentially continuing your study participation:


Patients With Multiple Sclerosis:

Patients With Ulcerative Colitis:

Germany:      +49 163 173 5556
Poland:           +48 696 646-063
Romania:       +40 729019606

Central contact: +49 172 630 49 21


IR Contact

Immunic, Inc.

1200 Avenue of the Americas, Suite 200
New York, NY 10036, USA
+1 332 2559811

Media and Investor Inquiries
Jessica Breu
Vice President Investor Relations and Communications
+49 89 2080 477 09

Rx Communications

Paula Schwartz
Managing Director
+1 917 322 2216